Cutting Edge Conversations: Discovering New Innovations in Oncology
Join experts, including Aptamer Group CTO, Dr David Bunka, for a conversation on recent progress in cancer research, including novel treatments, experimental therapies, and drug development.
- Dr David Bunka discusses how Optimer technology is enabling new strategies in cancer treatment, including the targeted delivery of diverse payloads to cancer cells for precision chemotherapy, or gene therapy approaches.
- This was a great session where we collaborated with Kromatid and BioIVT to discuss the latest developments in the field.
- Aptamer Group presentation begins at 08:41 and the Q&A is at 44:48.
View webinar (external source)